Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:1319-1327
Published online before print October 18, 2007, doi: 10.1161/CIRCRESAHA.107.155564
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/12/1319    most recent
CIRCRESAHA.107.155564v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, W. D.
Right arrow Articles by Taylor, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, W. D.
Right arrow Articles by Taylor, D. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bone Marrow Transplantation
*Coronary Artery Disease
Related Collections
Right arrow Pathophysiology
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2007;101:1319.)
© 2007 American Heart Association, Inc.


Integrative Physiology

Sex-Dependent Attenuation of Plaque Growth After Treatment With Bone Marrow Mononuclear Cells

Wendy D. Nelson*, Andrey G. Zenovich*, Harald C. Ott, Craig Stolen, Gabriel J. Caron, Angela Panoskaltsis-Mortari, Samuel A. Barnes, III, Xiangrong Xin, Doris A. Taylor

From the Center for Cardiovascular Repair (A.G.Z., G.J.C., D.A.T.), Department of Pediatrics (A.P.M.), and the School of Mathematics and Department of Biomedical Engineering (X.X.), University of Minnesota, Minneapolis; R&D Systems (W.D.N.), Minneapolis, Minn; Massachusetts General Hospital (H.C.O.), Boston; Boston Scientific Corporation (G.S.), Natick, Mass; and the School of Nursing (S.A.B.), University of Arkansas, Fayetteville.

Correspondence to Doris A. Taylor, PhD, Medtronic Bakken Professor of Integrative Biology, Physiology and Medicine, Director, Center for Cardiovascular Repair, University of Minnesota, 7-105A Nils Hasselmo Hall, 312 Church St SE, Minneapolis, MN 55455. E-mail dataylor{at}umn.edu

There are clinically relevant differences in symptomatology, risk stratification, and efficacy of therapies between men and women with coronary artery disease. Sex-based differences in plaque attenuation after administration of bone marrow mononuclear cells (BMNCs) are unknown. Forty-five male and 57 female apolipoprotein-E knockout (apoE–/–) mice were fed a high-fat diet. At 14 weeks of age, animals received 4 biweekly intravenous sex-matched (males, n=11; females, n=13) or -mismatched (males, n=12; females, n=14) BMNCs obtained from C57BL6/J mice. The rest of the apoE–/– mice were vehicle treated (males, n=13; females, n=20) or were age-matched untreated controls (males, n=9; females, n=10). Aortic plaque burden, progenitor cell profiles in bone marrow (BM) and 22 circulating cytokines/chemokines were examined 1 week following the final injection. Only female BMNCs infused into male apoE–/– recipients significantly decreased plaque formation (P<0.001). This reparative response univariately correlated with increased CD34+ (P=0.02), CD45+ (P=0.0001), and AC133+/CD34+ (P=0.001) cell percentages in the BM of recipients but not with total serum cholesterol or percentage of BM-CD31+/CD45low cells. In a multivariate analysis, BM-AC133+/CD34+ and BM-CD45+ percentage counts correlated with a lower plaque burden (P<0.05). Increased granulocyte colony-stimulating factor levels highly correlated with plaque attenuation (r=–0.86, P=0.0004). In untreated apoE–/– mice of either sex, BM-AC133+/CD34+ cells rose initially and then fell as plaque accumulated; however, BM-AC133+/CD34+ percentages were higher in females at all times (P≤0.01). We have demonstrated an atheroprotective effect of female-derived BMNCs administered to male atherosclerotic apoE–/– mice; this reparative response correlated with the upregulation of BM-AC133+/CD34+ and CD45+ cells and of circulating granulocyte colony-stimulating factor. Atherosclerotic female apoE–/– mice did not exhibit atheroprotection after BMNCs of either sex. Our findings may have implications for clinical cell therapy trials for coronary artery disease. Further exploration of sex-based differences in atheroprotection and vascular repair is warranted.


Key Words: atherosclerosis • bone marrow • cytokines • gender • stem cells